Published in J Mol Biol on November 17, 2009
HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med (2012) 3.17
Functional complexity and regulation through RNA dynamics. Nature (2012) 2.07
Structural determinants and mechanism of HIV-1 genome packaging. J Mol Biol (2011) 1.83
Structure of a conserved retroviral RNA packaging element by NMR spectroscopy and cryo-electron tomography. J Mol Biol (2010) 1.71
Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proc Natl Acad Sci U S A (2010) 1.46
Retroviral RNA dimerization and packaging: the what, how, when, where, and why. PLoS Pathog (2010) 1.21
Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem Sci (2011) 1.18
Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assembly. J Mol Biol (2011) 0.97
In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res (2013) 0.96
SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res (2011) 0.93
Distinct binding interactions of HIV-1 Gag to Psi and non-Psi RNAs: implications for viral genomic RNA packaging. RNA (2013) 0.93
Cell biology of retroviral RNA packaging. RNA Biol (2011) 0.92
Determining the frequency and mechanisms of HIV-1 and HIV-2 RNA copackaging by single-virion analysis. J Virol (2011) 0.90
Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms. Retrovirology (2012) 0.88
In vivo SELEX of single-stranded domains in the HIV-1 leader RNA. J Virol (2013) 0.84
Structural dynamics of retroviral genome and the packaging. Front Microbiol (2011) 0.83
Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions. J Virol (2014) 0.82
Murine leukemia virus RNA dimerization is coupled to transcription and splicing processes. Retrovirology (2010) 0.80
Transcriptional start site heterogeneity modulates the structure and function of the HIV-1 genome. Proc Natl Acad Sci U S A (2016) 0.78
Coordination of Genomic RNA Packaging with Viral Assembly in HIV-1. Viruses (2016) 0.77
Moloney murine leukemia virus genomic RNA packaged in the absence of a full complement of wild type nucleocapsid protein. Virology (2012) 0.76
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
Insights into the nuclear export of murine leukemia virus intron-containing RNA. RNA Biol (2015) 0.75
On the conformational stability of the smallest RNA kissing complexes maintained through two G·C base pairs. Biochem Biophys Res Commun (2017) 0.75
Selection of RNAs for constructing "Lighting-UP" biomolecular switches in response to specific small molecules. PLoS One (2013) 0.75
Identification of a high affinity nucleocapsid protein binding element from the bovine leukemia virus genome. Virus Res (2012) 0.75
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol (1981) 13.11
Retracted Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science (2009) 10.76
Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog (2006) 10.08
Form and function of retroviral proviruses. Science (1982) 8.80
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
Retracted XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A (2009) 6.72
Retroviral recombination and reverse transcription. Science (1990) 6.27
Selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE): quantitative RNA structure analysis at single nucleotide resolution. Nat Protoc (2006) 6.14
Structural features that give rise to the unusual stability of RNA hairpins containing GNRA loops. Science (1991) 6.01
The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol (2004) 4.91
Sequence and spacing requirements of a retrovirus integration site. J Mol Biol (1988) 4.89
RNA packaging. Curr Top Microbiol Immunol (1996) 4.88
Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol (2006) 4.43
Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology (2009) 4.11
Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol (1993) 3.78
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J Virol (1990) 3.40
Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol (1974) 3.37
Imaging the biogenesis of individual HIV-1 virions in live cells. Nature (2008) 2.92
Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci (1992) 2.79
gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. J Virol (1979) 2.68
Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol (2004) 2.61
Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol (1996) 2.59
Two alternating structures of the HIV-1 leader RNA. RNA (2001) 2.47
HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog (2007) 2.44
RNA chaperones, RNA annealers and RNA helicases. RNA Biol (2007) 2.41
Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat Struct Mol Biol (2004) 2.34
RNA flexibility in the dimerization domain of a gamma retrovirus. Nat Chem Biol (2005) 2.19
Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene. J Virol (1979) 2.16
Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci U S A (2009) 2.08
Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature (2004) 2.05
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J Virol (1993) 1.91
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe (2008) 1.91
Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J Mol Biol (1992) 1.89
Sequence relationship of glycosylated and unglycosylated gag polyproteins of Moloney murine leukemia virus. J Virol (1980) 1.83
Retroviral RNA packaging: a review. Arch Virol Suppl (1994) 1.80
Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc Natl Acad Sci U S A (2002) 1.76
Murine leukemia virus gag polyproteins: the peptide chain unique to Pr80 is located at the amino terminus. Virology (1978) 1.73
A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature (1999) 1.67
Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J Virol (2007) 1.66
Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein. Proc Natl Acad Sci U S A (1983) 1.63
An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV. Nucleic Acids Res (1990) 1.62
Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J Virol (2007) 1.60
Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther (1999) 1.57
NMR structure of the 101-nucleotide core encapsidation signal of the Moloney murine leukemia virus. J Mol Biol (2004) 1.53
Multiple secondary structure rearrangements during HIV-1 RNA dimerization. Biochemistry (2002) 1.50
A retroviral RNA kissing complex containing only two G.C base pairs. Proc Natl Acad Sci U S A (2000) 1.50
A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. J Virol (1993) 1.49
In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J Biol Chem (2002) 1.48
Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus. J Mol Biol (2005) 1.47
Structure of an RNA switch that enforces stringent retroviral genomic RNA dimerization. Proc Natl Acad Sci U S A (2006) 1.43
Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol (1999) 1.42
Nonrandom packaging of host RNAs in moloney murine leukemia virus. J Virol (2005) 1.30
A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol (2004) 1.30
A short autocomplementary sequence in the 5' leader region is responsible for dimerization of MoMuLV genomic RNA. Biochemistry (1995) 1.29
mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J Virol (2004) 1.28
A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription. Biochemistry (2000) 1.23
RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor. J Virol (2007) 1.22
Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition. J Mol Biol (2001) 1.19
Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication. J Virol (1999) 1.18
Dimerization of MoMuLV genomic RNA: redefinition of the role of the palindromic stem-loop H1 (278-303) and new roles for stem-loops H2 (310-352) and H3 (355-374). Biochemistry (1998) 1.17
Conformational analysis of the 5' leader and the gag initiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization. Nucleic Acids Res (1993) 1.17
HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization. J Mol Biol (2007) 1.14
Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes. J Virol (2002) 1.12
Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol (2004) 1.11
Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging. J Virol (2009) 1.11
An additional dimer linkage structure in Moloney murine leukemia virus RNA. J Mol Biol (1999) 1.07
Bipartite signal for genomic RNA dimerization in Moloney murine leukemia virus. J Virol (2002) 1.05
Composition and sequence-dependent binding of RNA to the nucleocapsid protein of Moloney murine leukemia virus. Biochemistry (2005) 1.03
Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology (2005) 0.95
Intermolecular interactions between retroviral Gag proteins in the nucleus. J Virol (2007) 0.92
Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus. J Virol (2005) 0.85
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci U S A (2006) 4.14
Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol (2002) 3.54
Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci U S A (2003) 3.20
How retroviruses select their genomes. Nat Rev Microbiol (2005) 2.99
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol (2002) 2.89
Antiviral inhibition of the HIV-1 capsid protein. J Mol Biol (2003) 2.27
Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature (2004) 2.05
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors. J Biol Chem (2001) 1.91
Structural determinants and mechanism of HIV-1 genome packaging. J Mol Biol (2011) 1.83
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. J Clin Oncol (2010) 1.79
Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol (2007) 1.78
Structure of a conserved retroviral RNA packaging element by NMR spectroscopy and cryo-electron tomography. J Mol Biol (2010) 1.71
NMR detection of structures in the HIV-1 5'-leader RNA that regulate genome packaging. Science (2011) 1.66
Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na. Leuk Res (2012) 1.65
NMR structure of the 101-nucleotide core encapsidation signal of the Moloney murine leukemia virus. J Mol Biol (2004) 1.53
Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol (2003) 1.52
Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med (Maywood) (2009) 1.46
Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J Mol Biol (2006) 1.38
The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology (2003) 1.36
Flexibility in the P2 domain of the HIV-1 Gag polyprotein. Protein Sci (2004) 1.33
Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J Mol Biol (2008) 1.31
Nonrandom packaging of host RNAs in moloney murine leukemia virus. J Virol (2005) 1.30
Isotope labeling strategies for NMR studies of RNA. J Biomol NMR (2009) 1.24
Retroviral RNA dimerization and packaging: the what, how, when, where, and why. PLoS Pathog (2010) 1.21
Involvement of protein kinase C and cyclic adenosine 3',5'-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells. Biol Reprod (2005) 1.17
Major groove width variations in RNA structures determined by NMR and impact of 13C residual chemical shift anisotropy and 1H-13C residual dipolar coupling on refinement. J Biomol NMR (2010) 1.17
Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol (2002) 1.16
Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packaging. J Mol Biol (2012) 1.14
Reverse micelle encapsulation of membrane-anchored proteins for solution NMR studies. Structure (2010) 1.13
Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol (2004) 1.11
Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol (2012) 1.10
Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse leydig cells. Mol Endocrinol (2005) 1.07
RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication. J Virol (2002) 1.05
Structure of the intact stem and bulge of HIV-1 Psi-RNA stem-loop SL1. J Mol Biol (2003) 1.05
Composition and sequence-dependent binding of RNA to the nucleocapsid protein of Moloney murine leukemia virus. Biochemistry (2005) 1.03
Potential intra- and intermolecular interactions involving the unique-5' region of the HIV-1 5'-UTR. Biochemistry (2008) 1.01
Packaging of host mY RNAs by murine leukemia virus may occur early in Y RNA biogenesis. J Virol (2009) 1.01
7SL RNA is retained in HIV-1 minimal virus-like particles as an S-domain fragment. J Virol (2010) 0.99
Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J Biol Chem (2002) 0.97
HIV-1 genetic recombination: experimental approaches and observations. AIDS Rev (2003) 0.97
Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA. J Ethnopharmacol (2008) 0.96
Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology (2005) 0.95
Future vision for the quality assurance of oncology clinical trials. Front Oncol (2013) 0.93
Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol (2002) 0.92
High affinity nucleocapsid protein binding to the muPsi RNA packaging signal of Rous sarcoma virus. J Mol Biol (2005) 0.92
Reevaluation of the requirement for TIP47 in human immunodeficiency virus type 1 envelope glycoprotein incorporation. J Virol (2013) 0.91
Database proton NMR chemical shifts for RNA signal assignment and validation. J Biomol NMR (2012) 0.90
Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis. J Virol (2007) 0.89
Enhanced survival of Plasmodium-infected mosquitoes during starvation. PLoS One (2012) 0.88
Synergistic activation of steroidogenic acute regulatory protein expression and steroid biosynthesis by retinoids: involvement of cAMP/PKA signaling. Endocrinology (2013) 0.88
Developmental arrest of Drosophila survival motor neuron (Smn) mutants accounts for differences in expression of minor intron-containing genes. RNA (2013) 0.88
Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J Virol (2004) 0.86
cis-Acting determinants of 7SL RNA packaging by HIV-1. J Virol (2012) 0.85
Regio-selective chemical-enzymatic synthesis of pyrimidine nucleotides facilitates RNA structure and dynamics studies. Chembiochem (2014) 0.83
The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct. PLoS One (2008) 0.83
Phenotypic variations in lipoid congenital adrenal hyperplasia. Pediatr Endocrinol Rev (2006) 0.83
Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. J Subst Abuse Treat (2013) 0.83
Dual-acting stapled peptides target both HIV-1 entry and assembly. Retrovirology (2013) 0.83
Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors. Transfusion (2011) 0.82
Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology (2006) 0.81
Inhibition of thromboxane a synthase activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells. Endocrinology (2007) 0.81
The HIV-1 matrix protein does not interact directly with the protein interactive domain of AP-3δ. Virus Res (2012) 0.81
Mutations that mimic phosphorylation of the HIV-1 matrix protein do not perturb the myristyl switch. Protein Sci (2007) 0.81
Mismatch extension during strong stop strand transfer and minimal homology requirements for replicative template switching during Moloney murine leukemia virus replication. J Mol Biol (2003) 0.80
Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination. J Virol (2007) 0.80
A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells. J Ethnopharmacol (2004) 0.80
6th international symposium on retroviral nucleocapsid. Retrovirology (2008) 0.79
Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing. RNA (2007) 0.79
Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex. J Mol Biol (2010) 0.78
Moloney murine leukemia virus genomic RNA packaged in the absence of a full complement of wild type nucleocapsid protein. Virology (2012) 0.76
STARD6 is expressed in steroidogenic cells of the ovary and can enhance de novo steroidogenesis. Exp Biol Med (Maywood) (2014) 0.76
Special issue: Structural and molecular biology of HIV. J Mol Biol (2011) 0.76
Identification of a high affinity nucleocapsid protein binding element from the bovine leukemia virus genome. Virus Res (2012) 0.75